The Rapid Emergence of Ceftazidime-Avibactam Resistance Mediated by KPC Variants in Carbapenem-Resistant <i>Klebsiella pneumoniae</i> in Zhejiang Province, China

• Main Authors: Congcong Liu (Author), Yuchen Wu (Author), Ling Huang (Author), Yanyan Zhang (Author), Qiaoling Sun (Author), Jiayue Lu (Author), Yu Zeng (Author), Ning Dong (Author), Chang Cai (Author), Zhangqi Shen (Author), Gongxiang Chen (Author), Rong Zhang (Author)
• Format: Book
• Published: MDPI AG, 2022-05-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Ceftazidime-avibactam (CAV) is a new treatment option against carbapenem-resistant <i>Klebsiella pneumoniae</i> (CRKP) infections. However, the rapid emergence of CAV resistance mediated by KPC variants has posed a severe threat to healthcare after its clinical application. The character...